Dragomir A - Search Results

1

Adherence to antihypertensive agents improves risk reduction of end-stage renal disease.

Roy L, White-Guay B, Dorais M, Dragomir A, Lessard M, Perreault S. Roy L, et al. Among authors: dragomir a. Kidney Int. 2013 Sep;84(3):570-7. doi: 10.1038/ki.2013.103. Epub 2013 May 22. Kidney Int. 2013. PMID: 23698228 Free article.

2

Trends and determinants of antiresorptive drug use for osteoporosis among elderly women.

Perreault S, Dragomir A, Desgagné A, Blais L, Rossignol M, Blouin J, Moride Y, Ste-Marie LG, Fernandès JC. Perreault S, et al. Among authors: dragomir a. Pharmacoepidemiol Drug Saf. 2005 Oct;14(10):685-95. doi: 10.1002/pds.1068. Pharmacoepidemiol Drug Saf. 2005. PMID: 15645517

3

Persistence and determinants of statin therapy among middle-aged patients for primary and secondary prevention.

Perreault S, Blais L, Lamarre D, Dragomir A, Berbiche D, Lalonde L, Laurier C, St-Maurice F, Collin J. Perreault S, et al. Among authors: dragomir a. Br J Clin Pharmacol. 2005 May;59(5):564-73. doi: 10.1111/j.1365-2125.2005.02355.x. Br J Clin Pharmacol. 2005. PMID: 15842555 Free PMC article.

4

Persistence with treatment in newly treated middle-aged patients with essential hypertension.

Perreault S, Lamarre D, Blais L, Dragomir A, Berbiche D, Lalonde L, Laurier C, St-Maurice F, Collin J. Perreault S, et al. Among authors: dragomir a. Ann Pharmacother. 2005 Sep;39(9):1401-8. doi: 10.1345/aph.1E548. Epub 2005 Aug 2. Ann Pharmacother. 2005. PMID: 16076920

5

Persistence and determinants of statin therapy among middle-aged patients free of cardiovascular disease.

Perreault S, Blais L, Dragomir A, Bouchard MH, Lalonde L, Laurier C, Collin J. Perreault S, et al. Among authors: dragomir a. Eur J Clin Pharmacol. 2005 Oct;61(9):667-74. doi: 10.1007/s00228-005-0980-z. Epub 2005 Oct 19. Eur J Clin Pharmacol. 2005. PMID: 16151763

6

Changes in pattern of use, clinical characteristics and persistence rate of hormone replacement therapy among postmenopausal women after the WHI publication.

Guay MP, Dragomir A, Pilon D, Moride Y, Perreault S. Guay MP, et al. Among authors: dragomir a. Pharmacoepidemiol Drug Saf. 2007 Jan;16(1):17-27. doi: 10.1002/pds.1273. Pharmacoepidemiol Drug Saf. 2007. PMID: 16794994

7

Discontinuation of antiresorptive therapies: a comparison between 1998-2001 and 2002-2004 among osteoporotic women.

Blouin J, Dragomir A, Ste-Marie LG, Fernandes JC, Perreault S. Blouin J, et al. Among authors: dragomir a. J Clin Endocrinol Metab. 2007 Mar;92(3):887-94. doi: 10.1210/jc.2006-1856. Epub 2007 Jan 2. J Clin Endocrinol Metab. 2007. PMID: 17200172

8

Impact of adherence to statins on coronary artery disease in primary prevention.

Bouchard MH, Dragomir A, Blais L, Bérard A, Pilon D, Perreault S. Bouchard MH, et al. Among authors: dragomir a. Br J Clin Pharmacol. 2007 Jun;63(6):698-708. doi: 10.1111/j.1365-2125.2006.02828.x. Epub 2007 Jan 3. Br J Clin Pharmacol. 2007. PMID: 17214831 Free PMC article.

9

Intraoperative floppy-iris syndrome associated with alpha1-adrenoreceptors: comparison of tamsulosin and alfuzosin.

Blouin MC, Blouin J, Perreault S, Lapointe A, Dragomir A. Blouin MC, et al. Among authors: dragomir a. J Cataract Refract Surg. 2007 Jul;33(7):1227-34. doi: 10.1016/j.jcrs.2007.03.032. J Cataract Refract Surg. 2007. PMID: 17586379

10

Comparison of persistence rates with angiotensin-converting enzyme inhibitors used in secondary and primary prevention of cardiovascular disease.

Gogovor A, Dragomir A, Savoie M, Perreault S. Gogovor A, et al. Among authors: dragomir a. Value Health. 2007 Sep-Oct;10(5):431-41. doi: 10.1111/j.1524-4733.2007.00247.x. Value Health. 2007. PMID: 17888108 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

282 results

Search Page

Filters